-- Merck KGaA's Cladribine Tablets for Multiple Sclerosis Approved in Russia
-- Angela Cullen
-- 2010-07-12T06:04:44Z
-- http://www.bloomberg.com/news/2010-07-12/merck-kgaa-s-cladribine-tablets-for-multiple-sclerosis-approved-in-russia.html

          
          
             Merck KGaA won approval to sell its
Cladribine pill to treat multiple sclerosis in Russia, where it
expects to start selling the medicine early next year, the
Darmstadt, Germany-based drugmaker said in an e-mailed statement
today.  
          
          


  


        